2020
Caspase-12 Is Present During Craniofacial Development and Participates in Regulation of Osteogenic Markers
VESELA, Barbora; Adela KRATOCHVILOVA; Eva SVANDOVA; Petr BENEŠ; Kamila ŘÍHOVÁ et al.Základní údaje
Originální název
Caspase-12 Is Present During Craniofacial Development and Participates in Regulation of Osteogenic Markers
Autoři
VESELA, Barbora; Adela KRATOCHVILOVA; Eva SVANDOVA; Petr BENEŠ; Kamila ŘÍHOVÁ ORCID; Anne POLIARD a Eva MATALOVA
Vydání
Frontiers in Cell and Developmental Biology, Lausanne, Frontiers Media S.A. 2020, 2296-634X
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10603 Genetics and heredity
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 6.684
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14310/20:00114552
Organizační jednotka
Přírodovědecká fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
caspase-12; bone; osteoblast; differentiation; alkaline phosphatase
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 7. 12. 2020 18:31, Mgr. Marie Novosadová Šípková, DiS.
Anotace
V originále
Caspases are evolutionary conserved proteases traditionally known as participating in apoptosis and inflammation but recently discovered also in association with other processes such as proliferation or differentiation. This investigation focuses on caspase-12, ranked among inflammatory caspases but displaying other, not yet defined functions. A screening analysis pointed to statistically significant (P < 0.001) increase in expression of caspase-12 in a decisive period of mandibular bone formation when the original mesenchymal condensation turns into vascularized bone tissue. Immunofluorescence analysis confirmed the presence of caspase-12 protein in osteoblasts. Therefore, the osteoblastic cell line MC3T3-E1 was challenged to investigate any impact of caspase-12 on the osteogenic pathways. Pharmacological inhibition of caspase-12 in MC3T3-E1 cells caused a statistically significant decrease in expression of some major osteogenic genes, including those for alkaline phosphatase, osteocalcin and Phex. This downregulation was further confirmed by an alkaline phosphatase activity assay and by a siRNA inhibition approach. Altogether, this study demonstrates caspase-12 expression and points to its unknown physiological engagement in bone cells during the course of craniofacial development.
Návaznosti
| GA19-14727S, projekt VaV |
|